Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Moderna Inc (NQ: MRNA )

148.85 +6.30 (+4.42%)
Streaming Delayed Price Updated: 10:06 AM EDT, Jun 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,300 Today
Via Benzinga
3 Pharma Stocks to Sell in August Before They Crash and Burn
Stay far away from these pharma stocks that are suffering from declining sales and weak pipelines of future products. 
Via InvestorPlace
Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare
Healthcare stocks are starting to shine in 2023 after bottoming out and MRK stock is particularly appealing. Here's why. 
Via InvestorPlace
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
Via Benzinga
Exposures COVID-19
Moderna Unusual Options Activity
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Why Moderna Stock Sunk Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower on Monday. 
Via Benzinga
Moderna (MRNA) Q2 2023 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2023. 
Via The Motley Fool
The 3 Best Healthcare Stocks to Buy in August
Healthcare is always the answer in the face of volatility. Here are the three best healthcare stocks to buy in the sector. 
Via InvestorPlace
3 Healthcare Stocks to Sell in August Before They Crash and Burn
Steer clear of these healthcare stocks, each of which is struggling with significant problems that are impacting their earnings. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
Moderna Sees 2023 Covid Vaccine Sales In Back Half Of The Year
The game's not over for Moderna. The company says most of its sales are yet to come. 
Via Investor's Business Daily
Check Out What Whales Are Doing With MRNA
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,400 Today
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
Moderna Lifts 2023 COVID-19 Vaccine Sales Outlook, Despite Over 90% Fall In Q2 Sales
Moderna Inc (NASDAQ: MRNA) shares are trading higher after the company reported a smaller-than-expected Q2 loss of $(3.62), beating  
Via Benzinga
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
The company hopes to launch an updated Covid booster shot this fall. But there are several complications. 
Via Investor's Business Daily
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost. 
Via Benzinga
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 46 stocks hit new 52-week lows. 
Via Benzinga
3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now
These underperforming companies have attractive valuations and long-term potential that investors shouldn't ignore. 
Via InvestorPlace
Why Novavax Stock Zoomed 13% Higher on Monday
A renewed fight against COVID-19 might be coming. 
Via The Motley Fool
7 Stocks to Buy Before They Surpass 2021 Highs
These 7 stocks to watch before new peaks are approaching 2021 highs and should move past those levels sometime this year. 
Via InvestorPlace
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday. 
Via Benzinga
Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
For investors who choose wisely, profits in healthcare stocks can be spectacular. But the losses can also be dramatic if you choose poorly. 
Via InvestorPlace
As COVID-19 Cases Spike This Summer, Healthcare Experts See It As Recurring Theme And Recommend These Measures
Via Benzinga
Earnings This Week: Apple, Amazon And AMD
It is another busy week for earnings. 
Via Talk Markets
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.